# Two Schedules of Hepatitis B Vaccination in Predialysis Chronic Renal Failure Patients

> **NCT01468051** · NA · COMPLETED · sponsor: **Tehran University of Medical Sciences** · enrollment: 51 (actual)

## Conditions studied

- Renal Failure

## Interventions

- **BIOLOGICAL:** four doses of Euvax B vaccine
- **BIOLOGICAL:** 20 μg (1 ml) three doses of Euvax B vaccine

## Key facts

- **NCT ID:** NCT01468051
- **Lead sponsor:** Tehran University of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-10
- **Primary completion:** 2008-10
- **Final completion:** 2008-10
- **Target enrollment:** 51 (ACTUAL)
- **Last updated:** 2011-11-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01468051

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01468051, "Two Schedules of Hepatitis B Vaccination in Predialysis Chronic Renal Failure Patients". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01468051. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*